Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: An EBMT survey

Bone Marrow Transplantation

Volumn 21, Issue 12, 1998, Pages 1213-1216

  Arnold, R ^a   De Witte, T ^b   Van Biezen, A ^c   Hermans, J ^d   Jacobsen, N ^e   Runde, V ^f   Gratwohl, A ^g   Apperley, J F ^h  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CLWP Registry   (Netherlands)

^d LEIDEN UNIVERSITY   (Netherlands)

^e Rigshospitalet   (Denmark)

^f UNIVERSITY HOSPITAL ESSEN   (Germany)

^g UNIVERSITY HOSPITAL BASEL   (Switzerland)

^h HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

MDS; sAML; Unrelated BMT

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CAUSE OF DEATH; CHILD; FEMALE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RELAPSE;

EID: 0031854181     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701269     Document Type: Article

References (12)

1. Ganser A, Hoelzer D. Clinical course of myelodysplastic syndromes. Hematol Oncol Clin North Am 1992; 6: 607-618.
2. Löffler H, Schmitz N, Gassmann W. Intensive chemotherapy and bone marrow transplantation for myelodysplastic syndromes. Hematol Oncol Clin North Am 1992; 6: 619-631.
3. De Witte T, Suciu S, Peetermans M et al. Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myelogenous leukemia following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG). Leukemia 1995; 9: 1805-1810.
4. Sutton L, Leblond V, Le Maignan C et al. Bone marrow transplantation for myelodysplastic syndrome and secondary leukemia: outcome of 86 patients. Bone Marrow Transplant 1991; 7 (Suppl. 2): 39.
5. De Witte T, Zwaan F, Hermans J et al. Allogeneic bone marrow transplantation for secondary leukemia and myelodysplastic syndrome: a survey by the Leukemia Working Party of the European Bone Marrow Transplantation Group (EBMTG). Br J Haematol 1990; 74: 151-155.
6. Longmore G, Guinan EC, Weinstein HJ et al. Bone marrow transplantation for myelodysplasia and secondary acute non-lymphoblastic leukemia. J Clin Oncol 1990; 8: 1707-1714.
7. O'Donnell JR, Nademanee AP, Snyder DS et al. Bone marrow transplantation for myelodysplastic and myeloproliferative syndromes. J Clin Oncol 1987; 5: 1822-1826.
8. Anderson JE, Appelbaum FR, Fisher LD et al. Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood 1993; 82: 677-681.
9. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. New Engl J Med 1993; 328: 593-602.
10. Anderson JE, Anasetti C, Appelbaum FR et al. Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia. Br J Haematol 1996; 93: 59-67.
11. Kaplan E, Meier P. Non-parametric estimation for incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
12. Cox DR. Regression model and life tables. JR Stat Soc Ser B 1972; 34: 187-220.